Impact of Azygos Venous Pathway Status on Surgical Difficulty in Patients with Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus: A Retrospective Study with a Large Cohort from China - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of Azygos Venous Pathway Status on Surgical Difficulty in Patients with Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus: A Retrospective Study with a Large Cohort from China

  • By

  • Chaoyan He

  • Rongjin Zhang

  • Hua Zhang

  • Shudong Zhang

  • Shumin Wang

  • February 3, 2026

Share

Objective:

To quantify the azygos-hemiazygos pathway in patients with renal cell carcinoma (RCC) and inferior vena cava (IVC) tumor thrombus by measuring maximum venous width and explore its significance in preoperative surgical planning.

Approach:
    Key Findings:
    • The azygos-hemiazygos pathway serves as a compensatory venous drainage route in patients with RCC and VTT, potentially influencing surgical outcomes.
    • Quantifying the maximum venous width at the aortic hiatus level can help predict surgical difficulty and intraoperative blood loss, aiding in preoperative planning.
    • Temporary clamping of the azygos-hemiazygos pathway may represent a viable strategy to reduce intraoperative bleeding.
    Interpretation:

    The status of the azygos-hemiazygos pathway is a critical factor in surgical planning for patients with RCC and VTT, as it may significantly influence intraoperative outcomes and strategies.

    Limitations:
    • The study is retrospective and may be subject to selection bias, which could affect the generalizability of the findings.
    • The definition of massive hemorrhage is not standardized and may vary across different surgical contexts, complicating comparisons.
    Conclusion:

    Assessing the azygos-hemiazygos pathway can provide valuable insights for surgical strategies in managing RCC with VTT, potentially improving patient outcomes by informing surgical approaches.

Original Source(s)

Impact of Azygos Venous Pathway Status on Surgical Difficulty in Patients with Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus: A Retrospective Study with a Large Cohort from China

  • by Chaoyan He, Rongjin Zhang, Hua Zhang, Shudong Zhang, Shumin Wang

  • February 3, 2026

Related Content

This Week’s CGT News: Duchenne Gene Therapy Hits Pivotal Mark

REGENXBIO reports phase III AAV data in Duchenne; plus: adenoviral immunotherapy, preconditioning-free CAR-T, in vivo immune programming, and DNA-guided CRISPR

  • May 25, 2026

  • 7 min
Dana-Farber’s Dr. Toni Choueiri Elected to the Association of American Physicians

Dana-Farber Cancer Institute’s Dr. Toni Choueiri, Director of the Lank Center for Genitourinary Oncology, was recently elected to one of the nation’s most prestigious medical organizations, The Association of American Physicians (AAP).

  • April 20, 2026

  • 2 min
International Kidney Cancer Collaboration with Leadership from Philadelphia

Kidney cancer is a growing global health problem, and both clinicians and policymakers need to prepare for a steep rise in the number of cases,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, and senior author of a landmark international study published in European Urology, which demonstrates that if current trends continue, kidney cancer cases could double by 2050

  • December 2, 2025

  • 3 min